These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26484742)

  • 41. Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa.
    Boyer S; Iwuji C; Gosset A; Protopopescu C; Okesola N; Plazy M; Spire B; Orne-Gliemann J; McGrath N; Pillay D; Dabis F; Larmarange J;
    AIDS Care; 2016; 28 Suppl 3(Suppl 3):39-51. PubMed ID: 27421051
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 12-month outcomes of HIV-infected infants identified at birth at one maternity site in Johannesburg, South Africa: an observational cohort study.
    Technau KG; Strehlau R; Patel F; Shiau S; Burke M; Conradie M; Sorour G; Sherman GG; Coovadia A; Murnane PM; Abrams EJ; Kuhn L
    Lancet HIV; 2018 Dec; 5(12):e706-e714. PubMed ID: 30416043
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
    Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
    AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of the PIMA point-of-care CD4 analyzer in VCT clinics in Zimbabwe.
    Mtapuri-Zinyowera S; Chideme M; Mangwanya D; Mugurungi O; Gudukeya S; Hatzold K; Mangwiro A; Bhattacharya G; Lehe J; Peter T
    J Acquir Immune Defic Syndr; 2010 Sep; 55(1):1-7. PubMed ID: 20622679
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
    PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multisite evaluation of a point-of-care instrument for CD4(+) T-cell enumeration using venous and finger-prick blood: the PIMA CD4.
    Diaw PA; Daneau G; Coly AA; Ndiaye BP; Wade D; Camara M; Mboup S; Kestens L; Dieye TN
    J Acquir Immune Defic Syndr; 2011 Dec; 58(4):e103-11. PubMed ID: 21909029
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Estimating implementation and operational costs of an integrated tiered CD4 service including laboratory and point of care testing in a remote health district in South Africa.
    Cassim N; Coetzee LM; Schnippel K; Glencross DK
    PLoS One; 2014; 9(12):e115420. PubMed ID: 25517412
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Laboratory-based performance evaluation of PIMA CD4+ T-lymphocyte count point-of-care by lay-counselors in Kenya.
    Zeh C; Rose CE; Inzaule S; Desai MA; Otieno F; Humwa F; Akoth B; Omolo P; Chen RT; Kebede Y; Samandari T
    J Immunol Methods; 2017 Sep; 448():44-50. PubMed ID: 28529048
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of Point-of-Care CD4 Testing on Retention in Care Among HIV-Positive Pregnant and Breastfeeding Women in the Context of Option B+ in Zimbabwe: A Cluster Randomized Controlled Trial.
    Joseph J; Gotora T; Erlwanger AS; Mushavi A; Zizhou S; Masuka N; Boeke CE; Mangwiro AZ
    J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S190-S197. PubMed ID: 28498189
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Implementation and operational research: Integrated pre-antiretroviral therapy screening and treatment for tuberculosis and cryptococcal antigenemia.
    Pac L; Horwitz MM; Namutebi AM; Auerbach BJ; Semeere A; Namulema T; Schwarz M; Bbosa R; Muruta A; Meya DB; Manabe YC
    J Acquir Immune Defic Syndr; 2015 Apr; 68(5):e69-76. PubMed ID: 25761234
    [TBL] [Abstract][Full Text] [Related]  

  • 51. "Closing the Gap": Provider Recommendations for Implementing Birth Point of Care HIV Testing.
    Wexler C; Kamau Y; Halder R; Brown M; Maloba M; Mabachi N; Sandbulte M; Gautney B; Goggin K; Odeny T; Finocchario-Kessler S
    AIDS Behav; 2019 Apr; 23(4):1073-1083. PubMed ID: 30542834
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Point-Of-Care p24 Infant Testing for HIV May Increase Patient Identification despite Low Sensitivity.
    Meggi B; Bollinger T; Mabunda N; Vubil A; Tobaiwa O; Quevedo JI; Loquiha O; Vojnov L; Peter TF; Jani IV
    PLoS One; 2017; 12(1):e0169497. PubMed ID: 28060886
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence, predictors, and management of advanced HIV disease among individuals initiating ART in Senegal, West Africa.
    Benzekri NA; Sambou JF; Ndong S; Tamba IT; Faye D; Diallo MB; Diatta JP; Faye K; Sall I; Sall F; Manga NM; Malomar JJ; Ndour CT; Hawes SE; Seydi M; Gottlieb GS
    BMC Infect Dis; 2019 Mar; 19(1):261. PubMed ID: 30876400
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Laboratory Evaluation of the Alere q Point-of-Care System for Early Infant HIV Diagnosis.
    Hsiao NY; Dunning L; Kroon M; Myer L
    PLoS One; 2016; 11(3):e0152672. PubMed ID: 27032094
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rapid point-of-care CD4 testing at mobile HIV testing sites to increase linkage to care: an evaluation of a pilot program in South Africa.
    Larson BA; Schnippel K; Ndibongo B; Xulu T; Brennan A; Long L; Fox MP; Rosen S
    J Acquir Immune Defic Syndr; 2012 Oct; 61(2):e13-7. PubMed ID: 22659650
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Using mHealth to Deliver a Home-Based Testing and Counseling Program to Improve Linkage to Care and ART Adherence in Rural South Africa.
    Comulada WS; Wynn A; van Rooyen H; Barnabas RV; Eashwari R; van Heerden A
    Prev Sci; 2019 Jan; 20(1):126-136. PubMed ID: 30259235
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Task-shifting point-of-care CD4+ testing to lay health workers in HIV care and treatment services in Namibia.
    Kaindjee-Tjituka F; Sawadogo S; Mutandi G; Maher AD; Salomo N; Mbapaha C; Neo M; Beukes A; Gweshe J; Muadinohamba A; Lowrance DW
    Afr J Lab Med; 2017; 6(1):643. PubMed ID: 29159139
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Feasibility of antiretroviral treatment monitoring in the era of decentralized HIV care: a systematic review.
    Pham MD; Romero L; Parnell B; Anderson DA; Crowe SM; Luchters S
    AIDS Res Ther; 2017 Jan; 14(1):3. PubMed ID: 28103895
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multidisease testing for HIV and TB using the GeneXpert platform: A feasibility study in rural Zimbabwe.
    Ndlovu Z; Fajardo E; Mbofana E; Maparo T; Garone D; Metcalf C; Bygrave H; Kao K; Zinyowera S
    PLoS One; 2018; 13(3):e0193577. PubMed ID: 29499042
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Point-of-care C-reactive protein and risk of early mortality among adults initiating antiretroviral therapy.
    Chaisson LH; Semitala FC; Asege L; Mwebe S; Katende J; Nakaye M; Andama AO; Marquez C; Atuhumuza E; Kamya M; Cattamanchi A; Yoon C
    AIDS; 2019 Apr; 33(5):895-902. PubMed ID: 30649057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.